Effectiveness and safety of vaginal suppositories for the treatment of the vaginal atrophy in postmenopausal women: An open, non-controlled clinical trial

European Review for Medical and Pharmacological Sciences

Volumn 12, Issue 6, 2008, Pages 411-416

  Costantino, Demetrio ^a   Guaraldi, C ^a  

^a Azienda USL Ferrara   (Italy)

Author keywords

Hyaluronic acid; Medical device; Menopause; Vaginal atrophy; Vaginal dryness

Indexed keywords

ALPHA TOCOPHEROL; HYALURONIC ACID; RETINOL; SANTES; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DYSPAREUNIA; EVENING DOSAGE; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; POSTMENOPAUSE; SCORING SYSTEM; TREATMENT DURATION; VAGINA ATROPHY; VAGINAL BURNING SENSATION; VAGINAL DRYNESS; VAGINAL INJURY; VAGINAL PRURITUS; VAGINITIS; VISUAL ANALOG SCALE;

ADULT; ATROPHY; FEMALE; HUMANS; HYALURONIC ACID; MIDDLE AGED; PATIENT COMPLIANCE; POSTMENOPAUSE; SUPPOSITORIES; VAGINA; VITAMIN A; VITAMIN E;

EID: 58249125494     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. ZAPANTIS G, SANTORO N. The menopausal transition: Characteristics and management. Best Pract Clin Endocrinol Metab 2003; 17: 33-52.
2. LEVINE KB, WILLIAMS RE, HARTMANN KE. Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active post-menopausal women. Menopause 2008; 15(4 Pt 1): 661-666.
3. MEHTA A, BACHMANN G. Vulvovaginal complaints. Clin Obstet Gynecol 2008; 51: 549-555.
4. GOLDSTEIN I, ALEXANDER JL. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and post-menopausal women. J Sex Med 2005; 2(Suppl 3): 154-165.
5. ROZENBERG S, PASTUN A, GEVERS R, MORILLO D. Estrogen therapy in older patients with recurrent urinary tract infections: A review. Int J Fertil Womens Med 2004; 49: 71-74.
6. VAN LUNSEN RH, LAAN E. Genital vascular responsiveness and sexual feeling in midlife women: Psychophysiologic, brain and genital imaging studies. Menopause 2004; 11(6 Pt 2): 741-748.
7. MILSOM I. Rationale prescribing for postmenopausal urogenital complaints. Drug Aging 1996; 9: 78-86.
8. PRELEVIC GM, KOCJAN T, MARKOU A. Hormone replacement therapy in postmenopausal women. Minerva Endocrinol 2005; 30: 27-36.
9. BERAL V, BULL D, REEVES G, MILLION WOMEN STUDY COLLABORATORS. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 2005; 365: 1543-1551.
10. CUZICK J. Hormone replacement therapy and the risk of breast cancer. Eur J Cancer 2008; 44: 2344-2349.
11. SIMUNIC V, BANOVIC I, CIGLAR S, JEREN L, PAVICIC BALDANI D, SPREM M. Local estrogen treatment in patients with urogenital symptoms. Int J Gynaecol Obstet 2003; 82: 187-197.
12. PALACIOS S, CASTELO-BRANCO C, CANCEL MJ, VAZQUEZ F. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in post-menopausal women on hormone therapy. Maturitas 2005; 50: 98-104.
13. JENKINS MR, SIKON AL. Update on nonhormonal approaches to menopausal management. Cleve Clin J Med 2008; 75(Suppl 4): S17-24.
14. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, FOOD AND DRUG ADMINISTRATION (FDA). CENTRE FOR DRUG EVALUATION AND RESEARCH (CDER). GUIDANCE FOR INDUSTRY. Bacterial vaginosis-Development antimicrobial drugs for treatment. Draft Guidance (July 1998).
15. BROWN MB, JONES SA. Hyaluronic acid: A unique topical vehicle for the localized delivery of drugs to the skin. J Eur Dermatol Venereol 2005; 19: 308-318.
16. ZALESKI KJ, KOLODKA T, CYWES-BENTLEY C, MCLOUGHLIN RM, DELANEY ML, CHARLTON BT, JOHNSON W, TZIANABOS AO. Hyaluronic acid binding peptides prevent experimental staphylococcal wound infection. Antimicrob Agents Chemother 2006; 50: 3856-3860.
17. FAVIA G, MARIGGIO MA, MAIORANO F, CASSANO A, CAPODIFERRO S, RIBATTI D. Accelerated wound healing of oral soft tissues and angiogenic effect induced by a pool of aminoacids combined to sodium hyaluronate (AMINOGAM). J Biol Regul Homeost Agents 2008; 22: 109-116.
18. NEGGERS YH, NANSEL TR, ANDREWS WW, SCHWEBKE JR, YU KF, GOLDENBERG RL, KLEBANHOFF MA. Dietary intake of selected nutrients affects bacterial vaginosis in women. J Nutr 2007; 137: 2128-2133.
19. ANT M. Diabetic vulvovaginitis treated with vitamin E suppositories. Am J Obstet Gynecol. 1954; 67: 407-410.
20. MORA JR, IWATA M, VON ANDRIAN UH. Vitamin effects on the immune system: Vitamins A and D take centre stage. Nat Rev Immunol 2008 Aug 8 (in press).
21. BIESALSKI HK, NOHR D. New aspects in vitamin A metabolism: The role of retinyl esters as systemic and local sources for retinol in mucous epithelia. J Nutr 2004; 134(12 Suppl): 3453S-3457S.
22. CLAGETT-DAME M, DELUCA HF. The role of vitamin A in mammalian reproduction and embryotic development. Annu Rev Nutr 2002; 22: 347-381.
23. MARCEAU G, GALLOT D, LEMERY D, SAPIN V. Metabolism of retinol during mammalian placental and embryonic development. Vitam Horm 2007; 75: 97-115.